Circulation Journal Issues Research Articles in Feb. 25, 2020 Edition
February 25, 2020
February 25, 2020
DALLAS, Texas, Feb. 25 -- Circulation, a journal from the American Heart Association, published research articles on the following topics in its Feb. 25, 2020 edition:
* Predicting Benefit From Evolocumab Therapy in Patients With Atherosclerotic Disease Using a Genetic Risk Score: Results From the FOURIER Trial
* Patients With High Genome-Wide Polygenic Risk Scores for Coronary Artery Disease May Receive Greater Clinical Benefit From Alirocumab Treatment in the ODYSSEY . . .
* Predicting Benefit From Evolocumab Therapy in Patients With Atherosclerotic Disease Using a Genetic Risk Score: Results From the FOURIER Trial
* Patients With High Genome-Wide Polygenic Risk Scores for Coronary Artery Disease May Receive Greater Clinical Benefit From Alirocumab Treatment in the ODYSSEY . . .